Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VALN
VALN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VALN News
Valneva SE to Report Q1 2026 Financial Results on May 13
6d ago
Newsfilter
Pomerantz LLP Investigates Valneva for Securities Fraud
May 01 2026
PRnewswire
Valneva Completes €84 Million Reserved Offering Successfully
Apr 30 2026
Newsfilter
Pomerantz LLP Investigates Valneva for Securities Fraud
Apr 28 2026
Globenewswire
Pomerantz LLP Investigates Valneva for Securities Fraud
Apr 21 2026
Globenewswire
Valneva SE Under Investigation for Securities Fraud
Apr 14 2026
Globenewswire
Valneva SE Under Investigation for Securities Fraud
Apr 02 2026
PRnewswire
Pomerantz LLP Investigates Valneva for Securities Fraud
Mar 31 2026
Globenewswire
Biotech Landscape Update: Regulatory Approvals and Mergers
Mar 27 2026
NASDAQ.COM
Valneva to Participate in World Vaccine Congress 2026
Mar 26 2026
Newsfilter
Valneva's Vaccine Trial Fails to Meet Primary Endpoint
Mar 24 2026
Globenewswire
Valneva's Lyme Disease Vaccine Candidate Shows Over 70% Efficacy
Mar 23 2026
NASDAQ.COM
Experimental Lyme Disease Vaccine Shows Over 70% Efficacy
Mar 23 2026
Yahoo Finance
Pfizer and Valneva Report Phase 3 Results for Lyme Disease Vaccine
Mar 23 2026
seekingalpha
Pfizer and Valneva Report Phase 3 Vaccine Trial Results
Mar 23 2026
NASDAQ.COM
Pfizer's Vaccine Candidate PF-07307405 Shows Over 70% Efficacy
Mar 23 2026
Newsfilter
Show More News
